Second-Half Vascepa Sales Growth Still in Focus for Amarin (AMRN); Aegis Maintains at 'Hold'

Go back to Second-Half Vascepa Sales Growth Still in Focus for Amarin (AMRN); Aegis Maintains at 'Hold'
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 15.97 +0.16 (1.01%)
Previous Close $15.81    52 Week High $3.65 
Open $15.66    52 Week Low $1.24 
Day High $16.47    P/E N/A 
Day Low $15.16    EPS $0.00 
Volume 124,816